Reply: Capecitabine and mitomycin C in patients with metastatic colorectal cancer resistant to fluorouracil and irinotecan

被引：0
|
作者：
G Chong
D Cunningham
机构：
[1] Royal Marsden Hospital,
[2] G1 Cancer/Lymphoma Unit,undefined
来源：
British Journal of Cancer | 2006年 / 94卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：937 / 937
相关论文
共 50 条
  • [21] Modified XELIRI (capecitabine plus irinotecan) for metastatic colorectal cancer
    Price, Timothy J.
    LANCET ONCOLOGY, 2018, 19 (05): : 587 - 589
  • [22] Continuous infusion of oxaliplatin plus chronomodulated capecitabine in 5-fluorouracil- and irinotecan-resistant advanced colorectal cancer patients
    Santini, D
    Vincenzi, B
    La Cesa, A
    Caricato, M
    Schiavon, G
    Spalletta, B
    Di Seri, M
    Coppola, R
    Rocci, L
    Tonini, G
    ONCOLOGY, 2005, 69 (01) : 27 - 34
  • [23] Capecitabine monotherapy in metastatic colorectal cancer Reply
    Holen, Kyle
    Saltz, Leonard
    LANCET ONCOLOGY, 2001, 2 (07): : 400 - 400
  • [24] Phase II study of irinotecan and mitomycin C in 5-fluorouracil-pretreated patients with advanced colorectal and gastric cancer
    Bamias, A
    Papamichael, D
    Syrigos, K
    Pavlidis, N
    JOURNAL OF CHEMOTHERAPY, 2003, 15 (03) : 275 - 281
  • [25] Mitomycin-C and Capecitabine (MIXE) as Salvage Treatment in Patients with Refractory Metastatic Colorectal Cancer: A Retrospective Study
    Saif, Muhammad Wasif
    Kaley, Kristin
    Brennan, Marianne
    Garcon, Marie Carmel
    Rodriguez, Gladys
    ANTICANCER RESEARCH, 2013, 33 (06) : 2743 - 2746
  • [26] Phase II study of weekly irinotecan and capecitabine treatment in metastatic colorectal cancer patients
    Li, Wenhua
    Xu, Jianming
    Shen, Lin
    Liu, Tianshu
    Guo, Weijian
    Zhang, Wen
    Chen, Zhiyu
    Zhu, Xiaodong
    Li, Jin
    BMC CANCER, 2014, 14
  • [27] Phase II study of weekly irinotecan and capecitabine treatment in metastatic colorectal cancer patients
    Wenhua Li
    Jianming Xu
    Lin Shen
    Tianshu Liu
    Weijian Guo
    Wen Zhang
    Zhiyu Chen
    Xiaodong Zhu
    Jin Li
    BMC Cancer, 14
  • [28] EFFICACY AND SAFETY OF CAPECITABINE AND IRINOTECAN (CAPIRI) IN PATIENTS (PTS) WITH METASTATIC COLORECTAL CANCER (MCRC)
    Bounedjar, Adda
    Smaili, Farida
    ANNALS OF ONCOLOGY, 2011, 22 : v99 - v99
  • [29] Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
    Hurwitz, H
    Fehrenbacher, L
    Novotny, W
    Cartwright, T
    Hainsworth, J
    Heim, W
    Berlin, J
    Baron, A
    Griffing, S
    Holmgren, E
    Ferrara, N
    Fyfe, G
    Rogers, B
    Ross, R
    Kabbinavar, F
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (23): : 2335 - 2342
  • [30] Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer.
    Saltz, LB
    Cox, JV
    Blanke, C
    Rosen, LS
    Fehrenbacher, L
    Moore, MJ
    Maroun, JA
    Ackland, SP
    Locker, PK
    Pirotta, N
    Elfring, GL
    Miller, LL
    NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (13): : 905 - 914
12345